Combination therapy of flaxseed and hesperidin enhances the effectiveness of lifestyle modification in cardiovascular risk control in prediabetes: a randomized controlled trial.
Zahra YariZahra Naser-NakhaeeElahe Karimi-ShahrbabakMakan CheraghpourMehdi HedayatiSeyede Marjan MohagheghShahrzad OmmiAzita HekmatdoostPublished in: Diabetology & metabolic syndrome (2021)
The trial was registered with ClinicalTrials.gov, number NCT03737422. Registered 11 November 2018. Retrospectively registered, https://clinicaltrials.gov/ct2/results?cond=&term=NCT03737422&cntry=&state=&city=&dist= .
Keyphrases
- combination therapy
- randomized controlled trial
- computed tomography
- metabolic syndrome
- systematic review
- study protocol
- preterm infants
- cardiovascular disease
- physical activity
- clinical trial
- weight loss
- phase iii
- image quality
- contrast enhanced
- magnetic resonance imaging
- type diabetes
- positron emission tomography
- preterm birth
- open label